RTN4 Protein (Nogo)

RTN4 Protein (Reticulon-4 / Nogo)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RTN4 Protein (Nogo)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RTN4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RTN4 (Nogo)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=RTN4" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">11 edges</a></td>
</tr>
</table>

Overview

RTN4 Protein (Reticulon-4 / Nogo)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">RTN4 Protein (Nogo)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RTN4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RTN4 (Nogo)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=RTN4" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">11 edges</a></td>
</tr>
</table>

Overview

Reticulon-4 (RTN4), commonly known as Nogo, is the most studied member of the reticulon protein family and a potent inhibitor of axonal regeneration in the central nervous system.[@bhatt2006][@schwab2010] Encoded by the [RTN4](/genes/rtn4) gene, Nogo exists in three major isoforms (Nogo-A, Nogo-B, Nogo-C) with distinct tissue distribution and functional profiles.[@bhatt2006] Nogo-A signals through the Nogo receptor complex (NgR1/LINGO-1/p75NTR or TROY) to activate RhoA-ROCK signaling, inducing growth cone collapse and blocking axonal sprouting.[@schwab2010] Beyond its canonical role in CNS injury, accumulating evidence implicates Nogo-A signaling in [Alzheimer's Disease](/diseases/alzheimers-disease), [multiple sclerosis](/diseases/multiple-sclerosis), and age-related synaptic decline.[@park2006][@he2004]

Structure

RTN4 produces three principal isoforms through alternative promoter usage and splicing:

• Nogo-A (~200 kDa): The largest isoform, predominantly expressed in oligodendrocytes and some [neurons](/entities/neurons). Contains two inhibitory domains — the Nogo-66 loop (66 amino acid extracellular segment between two transmembrane domains) that binds NgR1, and the Nogo-A-specific amino-terminal domain (amino-Nogo/NiG) that signals through sphingosine-1-phosphate receptor 2 (S1PR2).[@bhatt2006][@schwab2010]
• Nogo-B (~55 kDa): Widely expressed across vascular endothelium, smooth muscle, and immune cells. Lacks the amino-Nogo domain but retains the Nogo-66 region. Functions primarily in vascular remodeling through the Nogo-B receptor (NgBR/NUS1).[@bhatt2006]
• Nogo-C (~25 kDa): Expressed in skeletal muscle and some neuronal populations. Contains only the reticulon homology domain (RHD) and Nogo-66. Its neurological function remains less characterized.[@bhatt2006]

Normal Function

Axon Growth Inhibition

Nogo-A is a major myelin-associated inhibitor that restricts axonal plasticity in the adult CNS.[@schwab2010] Through the Nogo-66 domain binding to the NgR1/LINGO-1/p75NTR receptor complex, Nogo-A activates the small GTPase RhoA and its downstream effector ROCK (Rho-associated kinase), leading to growth cone collapse, neurite retraction, and inhibition of axonal sprouting.[@schwab2010] This signaling pathway serves to stabilize neural circuitry in the mature brain, preventing inappropriate axonal reorganization.

Myelin Stability

In [oligodendrocytes](/cell-types/oligodendrocytes), Nogo-A localizes to the innermost myelin wraps (adaxonal membrane) where it contributes to myelin sheath structural integrity and periodicity.[@bhatt2006] Loss of Nogo-A leads to subtle myelin abnormalities in mouse models, suggesting it plays a maintenance role in the oligodendrocyte-axon unit.

ER Morphology and Calcium Signaling

Through its RHD, RTN4 shapes ER tubular networks and influences ER-mitochondrial contact sites, which are critical for calcium signaling and lipid transfer.[@bhatt2006] This housekeeping function is shared across all reticulon family members and is relevant to the ER stress component of neurodegenerative disease.

Role in Neurodegeneration

Alzheimer's Disease

Nogo-A expression is elevated in hippocampal neurons of AD patients, and its receptor NgR1 colocalizes with [amyloid plaques](/mechanisms/amyloid-cascade).[@park2006][@he2004] Several mechanistic connections have been identified:

• Amyloid-beta interaction: NgR1 directly binds Aβ oligomers and fibrils, and Nogo-A/NgR1 signaling may mediate part of Aβ-induced synaptic toxicity by activating RhoA-ROCK-dependent dendritic spine retraction.[@park2006]
• [APP](/entities/app-protein) processing: Nogo-A interacts with the [beta-secretase](/entities/bace1) [BACE1](/proteins/bace1-protein), and overexpression of RTN family members (including RTN3) modulates amyloidogenic APP cleavage.[@he2004]
• Synaptic plasticity restriction: Age-related increases in Nogo-A signaling contribute to reduced synaptic plasticity and impaired [long-term potentiation](/mechanisms/long-term-potentiation) in aged [hippocampus](/brain-regions/hippocampus). Genetic deletion of NgR1 in aged mice restores youthful levels of ocular dominance plasticity.[@mcgee2005]

Spinal Cord Injury

Nogo-A is the primary barrier to functional axonal regeneration after spinal cord injury (SCI). Anti-Nogo-A antibodies (e.g., the humanized antibody ATI355/NG-101) promote axonal sprouting, formation of detour circuits, and functional recovery in rodent and primate SCI models.[@schwab2010][@kucher2018] Phase I clinical trials of intrathecal anti-Nogo-A antibodies in acute SCI patients have demonstrated safety and are progressing to efficacy testing.[@kucher2018]

Multiple Sclerosis

In [MS](/diseases/multiple-sclerosis), Nogo-A may limit remyelination by inhibiting oligodendrocyte precursor cell process extension needed for remyelination of denuded axons.[@karnezis2004] Anti-Nogo-A approaches are being explored as adjuncts to promote remyelination alongside immunomodulatory therapies.

Stroke Recovery

Post-stroke, Nogo-A restricts compensatory axonal sprouting from the intact hemisphere that could restore function. Anti-Nogo-A antibody treatment in rodent stroke models enhances corticospinal tract plasticity and improves skilled forelimb recovery.[@schwab2010]

Therapeutic Targeting

• Anti-Nogo-A antibodies: ATI355/NG-101 (Novartis) and ozanezumab have been tested in SCI and ALS clinical trials respectively. Ozanezumab did not meet primary endpoints in ALS (Phase II), but anti-Nogo strategies continue in SCI.[@kucher2018]
• NgR decoy receptors: Soluble NgR1-Fc fusion proteins that sequester Nogo-66 and other myelin inhibitors (MAG, OMgp) promote axonal regeneration in preclinical models.[@schwab2010]
• ROCK inhibitors: Downstream targeting of RhoA-ROCK signaling (e.g., fasudil) bypasses the receptor level and blocks growth cone collapse regardless of the upstream inhibitor. Fasudil has been tested in stroke recovery trials.[@schwab2010]
• Nogo-A in AD: Blocking NgR1 signaling to restore synaptic plasticity represents a mechanistically distinct therapeutic approach for cognitive decline, orthogonal to amyloid- or [tau](/proteins/tau)-targeting strategies.[@park2006][@mcgee2005]

See Also

• [Oligodendrocytes](/cell-types/oligodendrocytes)
• [Amyloid-Beta](/proteins/amyloid-beta)
• [BACE1](/proteins/bace1-protein)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [RhoA-ROCK Signaling](/mechanisms/rhoa-rock-signaling)

External Links

• [UniProt: RTN4 (Q9NQC3)](https://www.uniprot.org/uniprot/Q9NQC3)
• [NCBI Gene: RTN4](https://www.ncbi.nlm.nih.gov/gene/57142)
• [GeneCards: RTN4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RTN4)

References